Advertisement

Ads Placeholder
Loading...

VISEN Pharmaceuticals

2561.HK•HKSE
Healthcare
Drug Manufacturers - Specialty & Generic
HK$24.78
HK$-0.20(-0.80%)
Hong Kong Market opens in 5h 14m

VISEN Pharmaceuticals (2561.HK) Stock Overview

Explore VISEN Pharmaceuticals’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.7B
P/E Ratio-12.74
EPS (TTM)$-2.77
ROE-0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$32.31
3 Months$27.06
1 Year Target$14.48

2561.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of VISEN Pharmaceuticals (2561.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 28.17, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $14.48.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -12.74 and a market capitalization of 2.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.80%
5-Day Change
-8.22%
1-Month Change
-22.56%
3-Month Change
-26.29%
6-Month Change
-42.98%
Year-to-Date (YTD) Change
-26.29%
1-Year Change
-50.69%
3-Year Change
-63.98%
5-Year Change
-63.98%
All-Time (Max) Change
-63.98%

Contact Information

https://www.visenpharma.com/cn
NaN
Building B, Hengtai Lixiang Chuangxin Tower, Suzhou, NaN, 215000

Company Facts

580 Employees
IPO DateMar 21, 2025
CountryCN
Actively Trading

Frequently Asked Questions